Journals / Retina-Vitreus / 2008 / Cilt: 16 - Sayı: 2

Triamcinolone assisted retinal internal limiting membrane peeling during macular hole surgery

Maküla deliği cerrahisinde retina iç limitan membranın triamsinolon asetonit yardımıyla soyulması

Pages
113–117
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Triamcinolone acetonide is a useful adjunctive tool during PPV for macular hole by enhancing visibility of ILM and may result in successful outcomes.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To present the results of the technique in which triamcinolone assisted internal limiting membrane (ILM) peeling during pars plana vitrectomy (PPV) for idiopathic macular hole.
📊
Key Findings & Data:Materials and Methods: 0.1-0.2 ml triamcinolone (Kenakort 40 mg), diluted 1:5, was carefully injected over the macular area under the fluid following core vitrectomy via standard 3-port sclerotomy in 11 patients (4 female, 7 male; mean age 67±8 years).
💡
Conclusion & Impact:Conclusion: Triamcinolone acetonide is a useful adjunctive tool during PPV for macular hole by enhancing visibility of ILM and may result in successful outcomes.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Reoperasyon · Retina delinmeleri · Triamsinolon asetonit

Abstract

Purpose: To present the results of the technique in which triamcinolone assisted internal limiting membrane (ILM) peeling during pars plana vitrectomy (PPV) for idiopathic macular hole. Materials and Methods: 0.1-0.2 ml triamcinolone (Kenakort 40 mg), diluted 1:5, was carefully injected over the macular area under the fluid following core vitrectomy via standard 3-port sclerotomy in 11 patients (4 female, 7 male; mean age 67±8 years). ILM was peeled by using a forceps over the retinal surface in the form of maculorhexis while triamcinolone made ILM visible by specifically adhering it. C3F8 gas was used as internal tamponade at the end of surgery. Anatomic success was assessed by the help of optical coherence tomography and functional success was assessed by using Snellen visual acuity charts. Snellen visual acuity values were converted to logMAR equivalents for the statistical comparisons. Results: Mean follow-up time was 9±3 months (range, 3-15 months). One eye was pseudophakic, ten were phakic. At the last examination, mean Snellen visual acuity (0.43±0.10) logMAR equivalent ~0.4), was higher than that of baseline (0.10±0.02) (logMAR equivalent: 1.0) (p=0.005, Wilcoxon test). No complication was encountered during surgery. Macular hole was found closed in 10 (91%) eyes at the first attempt. The only eye with unclosed macular hole (9%) underwent a second PPV and the hole was closed at the last examination. Eight phakic eyes developed cataract and 7 of them underwent cataract extraction during the study period. Conclusion: Triamcinolone acetonide is a useful adjunctive tool during PPV for macular hole by enhancing visibility of ILM and may result in successful outcomes.

Özet

Amaç: İdiyopatik maküla deliği bulunan gözlerde, pars pla- na vitrektomi (PPV) cerrahisi esnasında retina iç limitan membranının (İLM) triamsinolon asetonit yardımıyla soyul- ması tekniğinin sonuçlarını sunmak. Gereç ve Yöntem: Maküla deliği bulunan 11 hastanın (4 ka- dın, 7 erkek; ortalama yaş: 67±8 yıl) 11 gözüne standart üç girişli PPV ile kor vitrektomi yapıldıktan sonra, sıvı altın- da maküla üzerine 0.1-0.2 ml, 1/5 oranında sulandırılmış triamsinolon asetonit (Kenakort 40mg) yavaşça enjekte edildi. Triamsinolon asetonit partiküllerinin üzerine çökel- mesiyle belirgin olarak görünür hale getirilen İLM, forseps yardımıyla maküloreksis şeklinde retina yüzeyinden so- yuldu. İntravitreal tamponad olarak C3F8 gazı kullanıldı. Anatomik başarı optik koherens tomografiyle, fonksiyonel başarı Snellen görme keskinliği eşeliyle değerlendirildi. İs- tatistik karşılaştırma için Snellen görme keskinlik değerleri logMAR değerlerine çevrildi. Bulgular: Hastalar ortalama 9±3 ay takip edildi (en az 3, en fazla 15 ay). Gözlerden biri psödofakik, onu fakikti. Son takipteki ortalama Snellen görme keskinliği (0.43±0.10) (logMAR karşılığı~0.4), ameliyat öncesi görme keskinliği- ne (0.10±0.02) (logMAR karşılığı: 1.0) göre anlamlı ola- rak yüksek bulundu (p=0.005, Wilcoxon testi). Peroperatif olarak hiçbir komplikasyona rastlanmadı. On gözde (%91) ilk müdahalede maküla deliği anatomik olarak kapandı. Bir hastada (%9) maküla deliği ilk operasyonda kapanma- dığından ikinci PPV yapıldı, bu hastanın yapılan son mua- yenesinde maküla deliği kapalı idi. Takip süresi boyunca belirgin katarakt gelişen 8 fakik hastanın 7’sine katarakt ameliyatı uygulandı. Sonuç: Maküla deliği cerrahisi sırasında triamsinolon asetonit kullanımı İLM’ye yapışarak görüntüleme kalitesini, buna bağlı olarak da cerrahide başarının artmasına katkıda bu- lunabilmektedir.

🔖

Cite This Article

ÇAKIR, M., ÇEKİÇ, O., YILMAZ, B., YILMAZ, Ö. F. (2008). Triamcinolone assisted retinal internal limiting membrane peeling during macular hole surgery. Retina-Vitreus, Cilt: 16 - Sayı: 2, 113–117. https://ajindex.com/articles/305218

References (19)

  1. Saxena S, Mclberg N, Thomas MA.: Management of idiopathic macu- lar holes. Ophthalmic Surg Lasers. 1996;27:618-627
  2. Gass JDM.: Idiopathic senile macular hole: its early stages and patho- genesis. Arch Ophthalmol. 1988;106:629-639
  3. McDonnell PJ, Fine SL, Hillis AI.: Clinical features of idiopathic macu- lar cysts and holes. Am J Ophthalmol. 1982;93:777-786
  4. Çekiç O, Batman C.: İdiopatik maküla delikleri ve güncel yaklaşımlar. Ret-Vit.1998;6:155-161
  5. Johnson RN, Gass JDM.: Idiopathic macular holes. Observations, sta- ges of formation, and implications for surgical intervention. Ophthal- mology. 1988;95:917-924
  6. Akiba J, Quiroz MA, Trempe CL.: Role of posterior vitreous detach- ment in idiopathic macular holes. Ophthalmology. 1990;97:1610- 1613
  7. Avila MP Jalkh AE, Freeman HM.: Biomicroskopic study of the vitreous in macular breaks. Ophthalmology. 1983;90:1277-1283
  8. Morgan CM, Schatz H.: Idiopathic macular holes. Am J Ophthalmol. 1985;99:437-444
  9. Kakehashi A, Schepens CL, Trempe CL.: Vitreomacular observations. II. Data on the pathogenesis of idiopathic macular breaks. Graefe’s Arch Clin Exp Ophthalmol. 1996;234:425-433
  10. Kelly NE, Wendel RT.: Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch Ophtlalmol. 1991;109:654-659
  11. Wendel RT, Patel AC, Kelly NE, et al.: Vitreous surgery for maculer holes. Ophthalmology. 1993;100:1671-1676
  12. Ryan E, Gilbert H.: Results of surgical treatment of recent-onset full- thickness idiopathic macular holes. Arch Ophthalmol. 1994;112:1545-1553
  13. Tornambe PE, Poliner LS, Grote K.: Macular hole surgery without face-down positining. A pilot study. Retina. 1997;17:179-185
  14. Brooks HL Jr.: Macular hole surgery with and without internal limiting membrane peeling. Ophthalmology. 2000;107:1939-1948
  15. Mester V, Kuhn F.: Internal limiting membrane removal in the. management of full-thickness macular holes. Am J Ophthalmol. 2000;129:769-777
  16. Haritoglou C, Gass C, Schaumberger M, et al.: Long term follow-up after macular hole surgery with internal limiting membrane peeling. Am J Ophthalmol. 2002;134:661-666
  17. Sheidow TG, Blinder KJ, Holekamp N, et al.: Outcome results in ma- cular hole surgery. Ophthalmology. 2003;110:1697-1701
  18. Sobacı G, Bayer A, Taş A.: İdiyopatik ve travmatik maküla deliklerinin vitrektomi ve iç limitan membran soyulması ile tedavisi: İlk sonuçları- mız. Ret-Vit. 2001;9:225-231
  19. Park DW, Sipperley JO, Sneed SR, et al.: Macular hole sur